The Eggplant Cancer Cure (For Skin Cancer)
By Bob Livingston April 2010
Most of you readers know that cancer of all types is an industry because it’s a medical monopoly. The standard conventional “treatment” for cancer in the U.S. is radiation, chemotherapy, and surgery. The result is very high cost and death in most cases. Of course, except for insurance and Medicare, this system would collapse overnight. It’s worthless and it causes a great amount of suffering before the patient dies. It has been proven many times that non-treated patients do not suffer nearly as much and sometimes not at all.
I have had the “Black Salve” cancer cream for a few years. I was told that it was formulated by Indians. Well, it works every time, at least as far as I know. It was sold by a lady in Las Vegas who got the formula from the Indians who created it. Well, you guessed it, the FDA Gestapo showed up at her door and advised her to stop selling the salve. How many millions and tens-of-millions of people do you suppose that conventional medicine has killed with their toxic and surgical intervention protocol?
Now here comes The Eggplant Skin Cancer Cure, by Dr. Bill E. Cham Ph.D, with the foreword by Dr. Jonathan V. Wright, M.D. Anything that Dr. Wright is associated with has my attention. If this cure is real, and I believe that it is, I don’t think that the FDA will allow it for very long.
Where to buy: Curaderm is available now from 1-800-976-2783, Fax 1-888-998-6889. In fact, they will send you a free listing of alternative health and anti-aging product vendors. No prescription is needed. Curaderm is for skin cancers but not for melanoma. There is hope that this same research will lead to the cure for all cancers.
There are many before and after color photos in The Eggplant Skin Cancer Cure book. These are very clear and valuable. Curaderm is an extract from the eggplant and its medical name is Curaderm BEC5, Curaderm BEC5 causes cancer cell death while cancer cells are “resting and dividing.”
Curaderm BEC5 is toxic only to cancer cells. Cell death from BEC5 is rapid and not dependent upon starving the cancer cells. Pharmacodynamic studies have determined that cancer cells have a specific receptor that recognizes and binds BEC%.
“The results of the Phase III trials determined that Curderm BEC5 produced success rates of 78% when Curaderm BEC5 was applied twice daily under occlusive dressing for eight weeks. If the treatment regime was extended to 12 weeks the success rates were virtually 100%. Only local skin irritation and erythema were observed as adverse reactions. Therefore, the treatment with Curaderm BEC5 was considered to be a safe therapy.” From page 61 of the book.
Curaderm is manufactured in Australia by Curaderm BEC5 Global Ltd., and their website is www.curadermBEC5global.com.
